American companies are embracing psychedelic therapy as a unique workplace benefit for employees seeking alternative treatments for mental health conditions. According to a report, around 50 firms have partnered with Enthea, a startup that provides third-party administrative services for health insurance plans, to offer this perk to their workers. An example is Dr. Bonner’s, a natural soap manufacturer, which granted approximately 7% of its 320 employees access to alternative therapy using ketamine, a tranquilizer with hallucinogenic properties. An anonymous survey revealed that 86% of those treated with ketamine experienced improvements in post-traumatic stress disorder symptoms, while 67% reported a reduction in symptoms associated with depression. Furthermore, 65% of participants noticed a decline in generalized anxiety disorder symptoms. Psychedelic drugs have gained traction in the tech industry, with tech moguls such as Elon Musk and Sergey Brin endorsing their usage. Scientific studies have corroborated the positive effects of psychedelics, often outperforming traditional medications in treating depression and anxiety. Johns Hopkins Medicine and other institutions have conducted research demonstrating the efficacy of psychedelic-assisted therapy, particularly with magic mushrooms, which have shown long-term reduction in depression symptoms. As a result, lawmakers in various states are considering decriminalizing or legalizing magic mushrooms for medical use. The therapeutic benefits of psilocybin have gained mainstream acceptance, with legislation being proposed across the political spectrum in states like Arizona, Hawaii, and Oklahoma. Other states such as California, Connecticut, New York, Utah, and Washington are considering legalization for therapeutic use or implementing pilot programs. However, bills related to magic mushrooms failed to advance in Virginia’s General Assembly this year due to political divisions.
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
